# directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor

> **NCT05795218** · — · TERMINATED · sponsor: **Aleva Neurotherapeutics SA** · enrollment: 21 (actual)

## Conditions studied

- Essential Tremor

## Interventions

- **DEVICE:** Deep Brain Stimulation

## Key facts

- **NCT ID:** NCT05795218
- **Lead sponsor:** Aleva Neurotherapeutics SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-21
- **Primary completion:** 2024-08-08
- **Final completion:** 2024-08-08
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Insolvency of the business
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05795218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05795218, "directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05795218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*